Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fujio Isono is active.

Publication


Featured researches published by Fujio Isono.


The Journal of Antibiotics | 2009

A novel assay of bacterial peptidoglycan synthesis for natural product screening.

Ryo Murakami; Yasunori Muramatsu; Emiko Minami; Kayoko Masuda; Yoshiharu Sakaida; Shuichi Endo; Takashi Suzuki; Osamu Ishida; Toshio Takatsu; Shunichi Miyakoshi; Masatoshi Inukai; Fujio Isono

Although a large number of microbial metabolites have been discovered as inhibitors of bacterial peptidoglycan biosynthesis, only a few inhibitors were reported for the pathway of UDP-MurNAc-pentapeptide formation, partly because of the lack of assays appropriate for natural product screening. Among the pathway enzymes, D-Ala racemase (Alr), D-Ala:D-Ala ligase (Ddl) and UDP-MurNAc-tripeptide:D-Ala-D-Ala transferase (MurF) are particularly attractive as antibacterial targets, because these enzymes are essential for growth and utilize low-molecular-weight substrates. Using dansylated UDP-MurNAc-tripeptide and L-Ala as the substrates, we established a cell-free assay to measure the sequential reactions of Alr, Ddl and MurF coupled with translocase I. This assay is sensitive and robust enough to screen mixtures of microbial metabolites, and enables us to distinguish the inhibitors for D-Ala–D-Ala formation, MurF and translocase I. D-cycloserine, the D-Ala-D-Ala pathway inhibitor, was successfully detected by this assay (IC50=1.7 μg ml−1). In a large-scale screening of natural products, we have identified inhibitors for D-Ala–D-Ala synthesis pathway, MurF and translocase I.


The Journal of Antibiotics | 1989

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties

Masatoshi Inukai; Fujio Isono; Shuji Takahashi; Ryuzo Enokita; Yoshiharu Sakaida; Tatsuo Haneishi


The Journal of Antibiotics | 1989

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation

Fujio Isono; Masatoshi Inukai; Shuji Takahashi; Tatsuo Haneishi; Takeshi Kinoshita; Harumitsu Kuwano


The Journal of Antibiotics | 1989

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties.

Fujio Isono; Toshiaki Katayama; Masatoshi Inukai; Tatsuo Haneishi


The Journal of Antibiotics | 1985

LACTOQUINOMYCIN, A NOVEL ANTICANCER ANTIBIOTIC

Nobuo Tanaka; Takayoshi Okabe; Fujio Isono; Masami Kashiwagi; Kuniko Nomoto; Masako Takahashi; Akira Shimazu; Toshio Nishimura


The Journal of Antibiotics | 1993

Mureidomycins E and F, minor components of mureidomycins.

Fujio Isono; Yoshiharu Sakaida; Shuji Takahashi; Takeshi Kinoshita; Takemichi Nakamura; Masatoshi Inukai


The Journal of Antibiotics | 1985

STUDIES ON ANTINEOPLASTIC ACTIVITY OF NAPHTHOMYCIN, A NAPHTHALENIC ANSAMYCIN, AND ITS MODE OF ACTION

Takayoshi Okabe; Bao Ding Yuan; Fujio Isono; Isao Sato; Hidesuke Fukazawa; Toshio Nishimura; Nobuo Tanaka


Biochemical and Biophysical Research Communications | 2004

Deletion of OSH3 gene confers resistance against ISP-1 in Saccharomyces cerevisiae.

Tatsuya Yano; Masatoshi Inukai; Fujio Isono


Archive | 1988

New antibiotics of the mureidomycin group, their preparation, and their therapeutic use

Tatsuo Haneishi; Masatoshi Inukai; Keiko Shimizu; Fujio Isono; Yoshiharu Sakaida; Takeshi Kinoshita


Archive | 1988

Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic use

Tatsuo Haneishi; Masatoshi Inukai; Keiko Shimizu; Fujio Isono; Yoshiharu Sakaida; Takeshi Kinoshita

Collaboration


Dive into the Fujio Isono's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge